Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, provided an update on its regulatory, compliance, and initial deployment activities for its telehealth platform in Venezuela. The company is actively testing and refining its platform, accessible at https://latamedai.org, as part of its early-stage development process.
The platform is designed to support remote patient engagement, care coordination, and integrate AI-driven healthcare analytics. Current efforts focus on enhancing functionality, data integration, and user experience. In parallel, the company is working with the Ministerio del Poder Popular para la Salud, including the Servicio Autónomo de Contraloría Sanitaria (SACS), to obtain the required Permiso Sanitario de Funcionamiento para Plataforma Digital. Management anticipates the permitting process may be completed in the near term, though no assurance is provided on timing or outcome.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated, 'Our focus is on building a scalable telehealth platform that can operate effectively within real-world healthcare environments. We are currently advancing platform testing, refinement, and regulatory alignment as we continue to build the foundation for broader deployment across Latin America. We expect a full launch in short order and upon receiving all regulatory approvals.'
This phase of deployment and regulatory alignment represents an important step toward broader operational rollout across target markets. The company continues to advance its digital health and AI platform, including telehealth infrastructure and AI-driven analytics. For more information, visit https://catalystcrewai.com or review SEC filings at www.sec.gov.
